{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T06:55:21Z","timestamp":1780556121693,"version":"3.54.1"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG30284"],"award-info":[{"award-number":["IG30284"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA192381"],"award-info":[{"award-number":["CA192381"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007052","name":"Universit\u00e0 degli Studi di Verona","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007052","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Metastasis Rev"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal malignancies, with limited therapeutic success and a persistently low 5-year survival rate. Despite significant advances in genomics and tumor biology, a fundamental challenge persists: to identify the elusive transformation from common benign pancreatic lesions to occasional malignant cellular identity. This review addresses a critical missing link in PDAC pathogenesis, focusing on when and where the switch to malignancy occurs, and why surgical intervention is often insufficient. We explore the biological and spatial\u2013temporal evolution of precancerous lesions, such as PanINs and IPMNs, and examine how phenotypic plasticity and overlapping cellular programs\u2014including squamous transdifferentiation, epithelial-to-mesenchymal transition (EMT), and acquisition of mesenchymal features\u2014contribute to early dissemination, treatment resistance, and surgical failure. Recognizing and characterizing these early molecular events is essential for rethinking therapeutic strategies, identifying actionable biomarkers, and redefining the temporal window when curative intervention is feasible.<\/jats:p>","DOI":"10.1007\/s10555-026-10326-1","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:46:24Z","timestamp":1773283584000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Early cellular plasticity promotes progression and dissemination in pancreatic adenocarcinoma"],"prefix":"10.1007","volume":"45","author":[{"given":"Giulio","family":"Innamorati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Malpeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Giacomello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Salvia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Wilkie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,12]]},"reference":[{"key":"10326_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/srep00161","volume":"1","author":"T Furukawa","year":"2011","unstructured":"Furukawa, T., Kuboki, Y., Tanji, E., Yoshida, S., Hatori, T., Yamamoto, M., Shibata, N., Shimizu, K., Kamatani, N., & Shiratori, K. (2011). Whole-exome sequencing uncovers frequent GNAS mutations in intraductal papillary mucinous neoplasms of the pancreas. Scientific Reports, 1, Article 161.","journal-title":"Scientific Reports"},{"issue":"18","key":"10326_CR2","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1016\/j.devcel.2025.07.002","volume":"60","author":"X Zhang","year":"2025","unstructured":"Zhang, X., Du, Y., Behrens, A., & Lan, L. (2025). Emerging insights into lineage plasticity in pancreatic cancer initiation, progression, and therapy resistance. Developmental Cell, 60(18), 2391\u20132406.","journal-title":"Developmental Cell"},{"issue":"4","key":"10326_CR3","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/s43018-023-00526-x","volume":"4","author":"S Barthel","year":"2023","unstructured":"Barthel, S., Falcomata, C., Rad, R., Theis, F. J., & Saur, D. (2023). Single-cell profiling to explore pancreatic cancer heterogeneity, plasticity and response to therapy. Nature Cancer, 4(4), 454\u2013467.","journal-title":"Nature Cancer"},{"issue":"12","key":"10326_CR4","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/S2468-1253(19)30323-1","volume":"4","author":"AP Klein","year":"2019","unstructured":"Klein, A. P. (2019). Pancreatic cancer: A growing burden. The Lancet Gastroenterology & Hepatology, 4(12), 895\u2013896.","journal-title":"The Lancet Gastroenterology & Hepatology"},{"issue":"12","key":"10326_CR5","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.1002\/wjs.12397","volume":"48","author":"C Ingaldi","year":"2024","unstructured":"Ingaldi, C., D\u2019Ambra, V., Ricci, C., Alberici, L., Minghetti, M., Grego, D., Cavallaro, V., & Casadei, R. (2024). Clinicopathological predictive factors in long-term survivors who underwent surgery for pancreatic ductal adenocarcinoma: A single-center propensity score matched analysis. World Journal of Surgery, 48(12), 3001\u20133013.","journal-title":"World Journal of Surgery"},{"issue":"11","key":"10326_CR6","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1038\/s41588-024-01914-4","volume":"56","author":"AM Khaliq","year":"2024","unstructured":"Khaliq, A. M., Rajamohan, M., Saeed, O., Mansouri, K., Adil, A., Zhang, C., Turk, A., Carstens, J. L., House, M., Hayat, S., et al. (2024). Spatial transcriptomic analysis of primary and metastatic pancreatic cancers highlights tumor microenvironmental heterogeneity. Nature Genetics, 56(11), 2455\u20132465.","journal-title":"Nature Genetics"},{"issue":"1","key":"10326_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54438-0","volume":"15","author":"Y Xu","year":"2024","unstructured":"Xu, Y., Wang, X., Li, Y., Mao, Y., Su, Y., Mao, Y., Yang, Y., Gao, W., Fu, C., Chen, W., et al. (2024). Multimodal single cell-resolved spatial proteomics reveal pancreatic tumor heterogeneity. Nature Communications, 15(1), Article 10100.","journal-title":"Nature Communications"},{"key":"10326_CR8","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djw036","author":"S Kato","year":"2016","unstructured":"Kato, S., Lippman, S. M., Flaherty, K. T., & Kurzrock, R. (2016). The conundrum of genetic \u201cdrivers\u201d in benign conditions. Journal of the National Cancer Institute. https:\/\/doi.org\/10.1093\/jnci\/djw036","journal-title":"Journal of the National Cancer Institute"},{"issue":"42","key":"10326_CR9","doi-asserted-by":"publisher","first-page":"4686","DOI":"10.1038\/s41388-022-02448-x","volume":"41","author":"T Evan","year":"2022","unstructured":"Evan, T., Wang, V. M. Y., & Behrens, A. (2022). The roles of intratumour heterogeneity in the biology and treatment of pancreatic ductal adenocarcinoma. Oncogene, 41(42), 4686\u20134695.","journal-title":"Oncogene"},{"issue":"3","key":"10326_CR10","doi-asserted-by":"publisher","first-page":"e288","DOI":"10.1097\/MPA.0000000000002301","volume":"53","author":"C Zheng","year":"2024","unstructured":"Zheng, C., Wang, J., Wang, J., Zhang, Q., & Liang, T. (2024). Cell of origin of pancreatic cancer: Novel findings and current understanding. Pancreas, 53(3), e288\u2013e297.","journal-title":"Pancreas"},{"key":"10326_CR11","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.033373","author":"J Burclaff","year":"2018","unstructured":"Burclaff, J., & Mills, J. C. (2018). Plasticity of differentiated cells in wound repair and tumorigenesis, part I: Stomach and pancreas. Disease Models & Mechanisms. https:\/\/doi.org\/10.1242\/dmm.033373","journal-title":"Disease Models & Mechanisms"},{"issue":"2","key":"10326_CR12","first-page":"201","volume":"45","author":"X Li","year":"2022","unstructured":"Li, X., He, J., & Xie, K. (2022). Molecular signaling in pancreatic ductal metaplasia: Emerging biomarkers for detection and intervention of early pancreatic cancer. Cellular Oncology (Dordrecht, Netherlands), 45(2), 201\u2013225.","journal-title":"Cellular Oncology (Dordrecht, Netherlands)"},{"issue":"5","key":"10326_CR13","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1097\/MPA.0000000000000786","volume":"46","author":"Y Matsuda","year":"2017","unstructured":"Matsuda, Y., Furukawa, T., Yachida, S., Nishimura, M., Seki, A., Nonaka, K., Aida, J., Takubo, K., Ishiwata, T., Kimura, W., et al. (2017). The prevalence and clinicopathological characteristics of high-grade pancreatic intraepithelial neoplasia: Autopsy study evaluating the entire pancreatic parenchyma. Pancreas, 46(5), 658\u2013664.","journal-title":"Pancreas"},{"issue":"4","key":"10326_CR14","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/MPA.0000000000002027","volume":"51","author":"DS Longnecker","year":"2022","unstructured":"Longnecker, D. S., & Suriawinata, A. A. (2022). Incidence of pancreatic intraepithelial neoplasia in an autopsy series. Pancreas, 51(4), 305\u2013309.","journal-title":"Pancreas"},{"issue":"5","key":"10326_CR15","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.jamcollsurg.2014.11.029","volume":"220","author":"MC Tan","year":"2015","unstructured":"Tan, M. C., Basturk, O., Brannon, A. R., Bhanot, U., Scott, S. N., Bouvier, N., LaFemina, J., Jarnagin, W. R., Berger, M. F., Klimstra, D., et al. (2015). GNAS and KRAS mutations define separate progression pathways in intraductal papillary mucinous neoplasm-associated carcinoma. Journal of the American College of Surgeons, 220(5), 845-854 e841.","journal-title":"Journal of the American College of Surgeons"},{"issue":"8","key":"10326_CR16","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1245\/s10434-019-07389-6","volume":"26","author":"S Gaujoux","year":"2019","unstructured":"Gaujoux, S., Parvanescu, A., Cesaretti, M., Silve, C., Bieche, I., Rebours, V., Levy, P., Sauvanet, A., & Cros, J. (2019). GNAS but not extended RAS mutations spectrum are associated with a better prognosis in intraductal pancreatic mucinous neoplasms. Annals of Surgical Oncology, 26(8), 2640\u20132650.","journal-title":"Annals of Surgical Oncology"},{"key":"10326_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17040705","author":"J Evans","year":"2025","unstructured":"Evans, J., Shivok, K., Chen, H. H., Gorgov, E., Bowne, W. B., Jain, A., Lavu, H., Yeo, C. J., & Nevler, A. (2025). Correlation of GNAS mutational status with oncologic outcomes in patients with resected intraductal papillary mucinous neoplasms. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers17040705","journal-title":"Cancers (Basel)"},{"issue":"8012","key":"10326_CR18","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41586-024-07359-3","volume":"629","author":"AM Braxton","year":"2024","unstructured":"Braxton, A. M., Kiemen, A. L., Grahn, M. P., Forjaz, A., Parksong, J., Mahesh Babu, J., Lai, J., Zheng, L., Niknafs, N., Jiang, L., et al. (2024). 3D genomic mapping reveals multifocality of human pancreatic precancers. Nature, 629(8012), 679\u2013687.","journal-title":"Nature"},{"issue":"10","key":"10326_CR19","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.37799","volume":"6","author":"J de la Fuente","year":"2023","unstructured":"de la Fuente, J., Chatterjee, A., Lui, J., Nehra, A. K., Bell, M. G., Lennon, R. J., Kassmeyer, B. A., Graham, R. P., Nagayama, H., Schulte, P. J., et al. (2023). Long-term outcomes and risk of pancreatic cancer in intraductal papillary mucinous neoplasms. JAMA Network Open, 6(10), Article e2337799.","journal-title":"JAMA Network Open"},{"issue":"8","key":"10326_CR20","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","volume":"186","author":"CJ Halbrook","year":"2023","unstructured":"Halbrook, C. J., Lyssiotis, C. A., di Pasca Magliano, M., & Maitra, A. (2023). Pancreatic cancer: Advances and challenges. Cell, 186(8), 1729\u20131754.","journal-title":"Cell"},{"issue":"3","key":"10326_CR21","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1002\/1878-0261.13576","volume":"18","author":"S Debernardi","year":"2024","unstructured":"Debernardi, S., Liszka, L., Ntala, C., Steiger, K., Esposito, I., Carlotti, E., Baker, A. M., McDonald, S., Graham, T., Dmitrovic, B., et al. (2024). Molecular characteristics of early-onset pancreatic ductal adenocarcinoma. Molecular Oncology, 18(3), 677\u2013690.","journal-title":"Molecular Oncology"},{"issue":"6","key":"10326_CR22","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.trecan.2016.05.005","volume":"2","author":"G Innamorati","year":"2016","unstructured":"Innamorati, G., Valenti, M. T., Giacomello, L., Dalle Carbonare, L., & Bassi, C. (2016). GNAS mutations: Drivers or co-pilots? Yet, promising diagnostic biomarkers. Trends in Cancer, 2(6), 282\u2013285.","journal-title":"Trends in Cancer"},{"issue":"6","key":"10326_CR23","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1016\/j.cmet.2019.02.005","volume":"29","author":"CM Hu","year":"2019","unstructured":"Hu, C. M., Tien, S. C., Hsieh, P. K., Jeng, Y. M., Chang, M. C., Chang, Y. T., Chen, Y. J., Chen, Y. J., Lee, E. Y. P., & Lee, W. H. (2019). High glucose triggers nucleotide imbalance through O-GlcNAcylation of key enzymes and induces KRAS mutation in pancreatic cells. Cell Metabolism, 29(6), 1334-1349 e1310.","journal-title":"Cell Metabolism"},{"issue":"2","key":"10326_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.108117","volume":"301","author":"R Suspene","year":"2025","unstructured":"Suspene, R., Raymond, K. A., Guardado-Calvo, P., Dairou, J., Bonhomme, F., Bonenfant, C., Guyetant, S., Lecomte, T., Pages, J. C., & Vartanian, J. P. (2025). Disruption of deoxyribonucleotide triphosphate biosynthesis leads to RAS proto-oncogene activation and perturbation of mitochondrial metabolism. The Journal of Biological Chemistry, 301(2), Article 108117.","journal-title":"The Journal of Biological Chemistry"},{"issue":"6","key":"10326_CR25","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1158\/2159-8290.CD-23-0013","volume":"13","author":"ES Carpenter","year":"2023","unstructured":"Carpenter, E. S., Elhossiny, A. M., Kadiyala, P., Li, J., McGue, J., Griffith, B. D., Zhang, Y., Edwards, J., Nelson, S., Lima, F., et al. (2023). Analysis of donor pancreata defines the transcriptomic signature and microenvironment of early neoplastic lesions. Cancer Discovery, 13(6), 1324\u20131345.","journal-title":"Cancer Discovery"},{"issue":"7722","key":"10326_CR26","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41586-018-0481-8","volume":"561","author":"AP Makohon-Moore","year":"2018","unstructured":"Makohon-Moore, A. P., Matsukuma, K., Zhang, M., Reiter, J. G., Gerold, J. M., Jiao, Y., Sikkema, L., Attiyeh, M. A., Yachida, S., Sandone, C., et al. (2018). Precancerous neoplastic cells can move through the pancreatic ductal system. Nature, 561(7722), 201\u2013205.","journal-title":"Nature"},{"issue":"4","key":"10326_CR27","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1093\/annonc\/mdx004","volume":"28","author":"K Allenson","year":"2017","unstructured":"Allenson, K., Castillo, J., San Lucas, F. A., Scelo, G., Kim, D. U., Bernard, V., Davis, G., Kumar, T., Katz, M., Overman, M. J., et al. (2017). High prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients. Annals of Oncology, 28(4), 741\u2013747.","journal-title":"Annals of Oncology"},{"key":"10326_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17243902","author":"L Brancato","year":"2025","unstructured":"Brancato, L., Osok, D., den Van Bossche, L., Cutsem, E. V., Bates, S. E., den Van Bossche, J., & Bogers, J. (2025). CA19-9 as a dynamic biomarker for continuous monitoring of therapeutic efficacy in pancreatic adenocarcinoma. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers17243902","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10326_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0184451","volume":"12","author":"GA Clawson","year":"2017","unstructured":"Clawson, G. A., Matters, G. L., Xin, P., McGovern, C., Wafula, E., dePamphilis, C., Meckley, M., Wong, J., Stewart, L., D\u2019Jamoos, C., et al. (2017). Stealth dissemination\" of macrophage-tumor cell fusions cultured from blood of patients with pancreatic ductal adenocarcinoma. PLoS ONE, 12(9), Article e0184451.","journal-title":"PLoS ONE"},{"key":"10326_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-08927-x","author":"G Pei","year":"2025","unstructured":"Pei, G., Min, J., Rajapakshe, K. I., Branchi, V., Liu, Y., Selvanesan, B. C., Thege, F., Sadeghian, D., Zhang, D., Cho, K. S., et al. (2025). Spatial mapping of transcriptomic plasticity in metastatic pancreatic cancer. Nature. https:\/\/doi.org\/10.1038\/s41586-025-08927-x","journal-title":"Nature"},{"issue":"1","key":"10326_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36296-4","volume":"14","author":"G Werba","year":"2023","unstructured":"Werba, G., Weissinger, D., Kawaler, E. A., Zhao, E., Kalfakakou, D., Dhara, S., Wang, L., Lim, H. B., Oh, G., Jing, X., et al. (2023). Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma and its tumor microenvironment. Nature Communications, 14(1), Article 797.","journal-title":"Nature Communications"},{"issue":"5","key":"10326_CR32","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1158\/1078-0432.CCR-19-1496","volume":"26","author":"HC Law","year":"2020","unstructured":"Law, H. C., Lagundzin, D., Clement, E. J., Qiao, F., Wagner, Z. S., Krieger, K. L., Costanzo-Garvey, D., Caffrey, T. C., Grem, J. L., DiMaio, D. J., et al. (2020). The proteomic landscape of pancreatic ductal adenocarcinoma liver metastases identifies molecular subtypes and associations with clinical response. Clinical Cancer Research, 26(5), 1065\u20131076.","journal-title":"Clinical Cancer Research"},{"issue":"6","key":"10326_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2025.100726","volume":"38","author":"TN Alver","year":"2025","unstructured":"Alver, T. N., Bergholtz, H., Holm, M. B., Dorg, L. T., Skrede, M. L., Kure, E. H., & Verbeke, C. S. (2025). Spatial transcriptomics reveals cancer and stromal cell heterogeneity between center and invasive front of pancreatic cancer. Modern Pathology, 38(6), Article 100726.","journal-title":"Modern Pathology"},{"issue":"1","key":"10326_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00780-4","volume":"6","author":"L Huang","year":"2021","unstructured":"Huang, L., Guo, Z., Wang, F., & Fu, L. (2021). KRAS mutation: From undruggable to druggable in cancer. Signal Transduction and Targeted Therapy, 6(1), Article 386.","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"1\u20132","key":"10326_CR35","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.cell.2011.11.025","volume":"148","author":"AD Rhim","year":"2012","unstructured":"Rhim, A. D., Mirek, E. T., Aiello, N. M., Maitra, A., Bailey, J. M., McAllister, F., Reichert, M., Beatty, G. L., Rustgi, A. K., Vonderheide, R. H., et al. (2012). EMT and dissemination precede pancreatic tumor formation. Cell, 148(1\u20132), 349\u2013361.","journal-title":"Cell"},{"key":"10326_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14133293","author":"Y Masugi","year":"2022","unstructured":"Masugi, Y. (2022). The desmoplastic stroma of pancreatic cancer: Multilayered levels of heterogeneity, clinical significance, and therapeutic opportunities. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers14133293","journal-title":"Cancers (Basel)"},{"issue":"11","key":"10326_CR37","doi-asserted-by":"publisher","first-page":"4366","DOI":"10.1158\/0008-5472.CAN-09-4057","volume":"70","author":"E Makareeva","year":"2010","unstructured":"Makareeva, E., Han, S., Vera, J. C., Sackett, D. L., Holmbeck, K., Phillips, C. L., Visse, R., Nagase, H., & Leikin, S. (2010). Carcinomas contain a matrix metalloproteinase-resistant isoform of type I collagen exerting selective support to invasion. Cancer Research, 70(11), 4366\u20134374.","journal-title":"Cancer Research"},{"issue":"7","key":"10326_CR38","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/s41563-020-0615-x","volume":"19","author":"T Panciera","year":"2020","unstructured":"Panciera, T., Citron, A., Di Biagio, D., Battilana, G., Gandin, A., Giulitti, S., Forcato, M., Bicciato, S., Panzetta, V., Fusco, S., et al. (2020). Reprogramming normal cells into tumour precursors requires ECM stiffness and oncogene-mediated changes of cell mechanical properties. Nature Materials, 19(7), 797\u2013806.","journal-title":"Nature Materials"},{"issue":"2","key":"10326_CR39","doi-asserted-by":"publisher","first-page":"e205","DOI":"10.1097\/MPA.0000000000002277","volume":"53","author":"P Salu","year":"2024","unstructured":"Salu, P., & Reindl, K. M. (2024). Advancements in preclinical models of pancreatic cancer. Pancreas, 53(2), e205\u2013e220.","journal-title":"Pancreas"},{"issue":"1","key":"10326_CR40","doi-asserted-by":"publisher","DOI":"10.1101\/pdb.prot078360","volume":"2016","author":"NM Aiello","year":"2016","unstructured":"Aiello, N. M., Rhim, A. D., & Stanger, B. Z. (2016). Orthotopic injection of pancreatic cancer cells. Cold Spring Harbor Protocols, 2016(1), Article pdb.prot078360.","journal-title":"Cold Spring Harbor Protocols"},{"issue":"12","key":"10326_CR41","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1038\/s41388-021-01706-8","volume":"40","author":"J Yamaguchi","year":"2021","unstructured":"Yamaguchi, J., Kokuryo, T., Yokoyama, Y., Ebata, T., Ochiai, Y., & Nagino, M. (2021). Premalignant pancreatic cells seed stealth metastasis in distant organs in mice. Oncogene, 40(12), 2273\u20132284.","journal-title":"Oncogene"},{"issue":"4","key":"10326_CR42","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s10585-023-10248-0","volume":"41","author":"C Rodriguez-Tirado","year":"2024","unstructured":"Rodriguez-Tirado, C., & Sosa, M. S. (2024). How much do we know about the metastatic process? Clinical & Experimental Metastasis, 41(4), 275\u2013299.","journal-title":"Clinical & Experimental Metastasis"},{"issue":"8060","key":"10326_CR43","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/s41586-025-08671-2","volume":"640","author":"L Perelli","year":"2025","unstructured":"Perelli, L., Zhang, L., Mangiameli, S., Giannese, F., Mahadevan, K. K., Peng, F., Citron, F., Khan, H., Le, C., Gurreri, E., et al. (2025). Evolutionary fingerprints of epithelial-to-mesenchymal transition. Nature, 640(8060), 1083\u20131092.","journal-title":"Nature"},{"issue":"1","key":"10326_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-09714-x","volume":"22","author":"O Nordgard","year":"2022","unstructured":"Nordgard, O., Lapin, M., Tjensvoll, K., Oltedal, S., Edland, K. H., Neverdahl, N. B., Fostenes, D., Garresori, H., Glenjen, N., Smaaland, R., et al. (2022). Prognostic value of disseminated tumor cells in unresectable pancreatic ductal adenocarcinoma: A prospective observational study. BMC Cancer, 22(1), Article 609.","journal-title":"BMC Cancer"},{"issue":"1","key":"10326_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02250-9","volume":"24","author":"S Yang","year":"2025","unstructured":"Yang, S., Seo, J., Choi, J., Kim, S. H., Kuk, Y., Park, K. C., Kang, M., Byun, S., & Joo, J. Y. (2025). Towards understanding cancer dormancy over strategic hitching up mechanisms to technologies. Molecular Cancer, 24(1), Article 47.","journal-title":"Molecular Cancer"},{"issue":"1","key":"10326_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2020.100899","volume":"14","author":"JS Wu","year":"2021","unstructured":"Wu, J. S., Jiang, J., Chen, B. J., Wang, K., Tang, Y. L., & Liang, X. H. (2021). Plasticity of cancer cell invasion: Patterns and mechanisms. Translational Oncology, 14(1), Article 100899.","journal-title":"Translational Oncology"},{"issue":"7","key":"10326_CR47","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/j.cmet.2021.04.002","volume":"33","author":"MR Zanotelli","year":"2021","unstructured":"Zanotelli, M. R., Zhang, J., & Reinhart-King, C. A. (2021). Mechanoresponsive metabolism in cancer cell migration and metastasis. Cell Metabolism, 33(7), 1307\u20131321.","journal-title":"Cell Metabolism"},{"key":"10326_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1586959","volume":"16","author":"Y Zhang","year":"2025","unstructured":"Zhang, Y., Li, W., Niu, J., Fan, Z., Li, X., & Zhang, H. (2025). Reprogramming of glucose metabolism in pancreatic cancer: Mechanisms, implications, and therapeutic perspectives. Frontiers in Immunology, 16, Article 1586959.","journal-title":"Frontiers in Immunology"},{"key":"10326_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2023.1113739","volume":"10","author":"Z Li","year":"2023","unstructured":"Li, Z., Wang, Q., Huang, X., Yang, M., Zhou, S., Li, Z., Fang, Z., Tang, Y., Chen, Q., Hou, H., et al. (2023). Lactate in the tumor microenvironment: A rising star for targeted tumor therapy. Frontiers in Nutrition, 10, Article 1113739.","journal-title":"Frontiers in Nutrition"},{"issue":"8","key":"10326_CR50","doi-asserted-by":"publisher","first-page":"4265","DOI":"10.1007\/s10238-023-01229-4","volume":"23","author":"SO Imodoye","year":"2023","unstructured":"Imodoye, S. O., & Adedokun, K. A. (2023). EMT-induced immune evasion: Connecting the dots from mechanisms to therapy. Clinical and Experimental Medicine, 23(8), 4265\u20134287.","journal-title":"Clinical and Experimental Medicine"},{"key":"10326_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1563303","volume":"16","author":"XY Gu","year":"2025","unstructured":"Gu, X. Y., Yang, J. L., Lai, R., Zhou, Z. J., Tang, D., Hu, L., & Zhao, L. J. (2025). Impact of lactate on immune cell function in the tumor microenvironment: Mechanisms and therapeutic perspectives. Frontiers in Immunology, 16, Article 1563303.","journal-title":"Frontiers in Immunology"},{"issue":"5","key":"10326_CR52","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.hpb.2024.02.001","volume":"26","author":"FP Robertson","year":"2024","unstructured":"Robertson, F. P., Cameron, A., Spiers, H. V. M., Joseph, N., Taylor, E., Ratnayake, B., Jamieson, N. B., & Pandanaboyana, S. (2024). Evidence for molecular subtyping in pancreatic ductal adenocarcinoma: A systematic review. HPB\u202f: the official journal of the International Hepato Pancreato Biliary Association, 26(5), 609\u2013617.","journal-title":"HPB : the official journal of the International Hepato Pancreato Biliary Association"},{"issue":"1","key":"10326_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31719-0","volume":"13","author":"Q Song","year":"2022","unstructured":"Song, Q., Yang, Y., Jiang, D., Qin, Z., Xu, C., Wang, H., Huang, J., Chen, L., Luo, R., Zhang, X., et al. (2022). Proteomic analysis reveals key differences between squamous cell carcinomas and adenocarcinomas across multiple tissues. Nature Communications, 13(1), Article 4167.","journal-title":"Nature Communications"},{"issue":"9","key":"10326_CR54","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.trecan.2024.06.007","volume":"10","author":"TR de Back","year":"2024","unstructured":"de Back, T. R., van Hooff, S. R., Sommeijer, D. W., & Vermeulen, L. (2024). Transcriptomic subtyping of gastrointestinal malignancies. Trends in Cancer, 10(9), 842\u2013856.","journal-title":"Trends in Cancer"},{"issue":"5","key":"10326_CR55","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.suc.2024.04.001","volume":"104","author":"JJ Lee","year":"2024","unstructured":"Lee, J. J., & Yeh, J. J. (2024). Updates in molecular profiling of pancreatic ductal adenocarcinoma. Surgical Clinics of North America, 104(5), 939\u2013950.","journal-title":"Surgical Clinics of North America"},{"issue":"3","key":"10326_CR56","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1158\/2159-8290.CD-20-0633","volume":"11","author":"BM Flowers","year":"2021","unstructured":"Flowers, B. M., Xu, H., Mulligan, A. S., Hanson, K. J., Seoane, J. A., Vogel, H., Curtis, C., Wood, L. D., & Attardi, L. D. (2021). Cell of origin influences pancreatic cancer subtype. Cancer Discovery, 11(3), 660\u2013677.","journal-title":"Cancer Discovery"},{"key":"10326_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2025.102479","volume":"60","author":"J Iovanna","year":"2025","unstructured":"Iovanna, J., Fraunhoffer, N., Urrutia, R., & Dusetti, N. (2025). Understanding the heterogeneity of pancreatic ductal adenocarcinoma. Translational Oncology, 60, Article 102479.","journal-title":"Translational Oncology"},{"issue":"4","key":"10326_CR58","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.ccell.2024.02.017","volume":"42","author":"P Di Chiaro","year":"2024","unstructured":"Di Chiaro, P., Nacci, L., Arco, F., Brandini, S., Polletti, S., Palamidessi, A., Donati, B., Soriani, C., Gualdrini, F., Frige, G., et al. (2024). Mapping functional to morphological variation reveals the basis of regional extracellular matrix subversion and nerve invasion in pancreatic cancer. Cancer Cell, 42(4), 662-681 e610.","journal-title":"Cancer Cell"},{"issue":"1","key":"10326_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02003-0","volume":"23","author":"JK Park","year":"2024","unstructured":"Park, J. K., Jeong, H. O., Kim, H., Choi, J. H., Lee, E. M., Kim, S., Jang, J., Choi, D. W., Lee, S. H., Kim, K. M., et al. (2024). Single-cell transcriptome analysis reveals subtype-specific clonal evolution and microenvironmental changes in liver metastasis of pancreatic adenocarcinoma and their clinical implications. Molecular Cancer, 23(1), Article 87.","journal-title":"Molecular Cancer"},{"issue":"6","key":"10326_CR60","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.devcel.2018.05.027","volume":"45","author":"NM Aiello","year":"2018","unstructured":"Aiello, N. M., Maddipati, R., Norgard, R. J., Balli, D., Li, J., Yuan, S., Yamazoe, T., Black, T., Sahmoud, A., Furth, E. E., et al. (2018). EMT subtype influences epithelial plasticity and mode of cell migration. Developmental Cell, 45(6), 681-695 e684.","journal-title":"Developmental Cell"},{"key":"10326_CR61","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.actbio.2025.11.031","volume":"209","author":"MR Pickett","year":"2026","unstructured":"Pickett, M. R., Kamra, M., Castilla-Casadiego, D. A., Noori, S., Matsui, W., Rosales, A. M., Zoldan, J., & Parekh, S. H. (2026). Collagen nanofiber alignment attenuates leader-follower energetic and metabolic differences during collective migration in pancreatic cancer. Acta Biomaterialia, 209, 183\u2013193.","journal-title":"Acta Biomaterialia"},{"key":"10326_CR62","doi-asserted-by":"publisher","DOI":"10.1172\/JCI191943","author":"R Maddipati","year":"2025","unstructured":"Maddipati, R. (2025). Metastatic heterogeneity in pancreatic cancer: Mechanisms and opportunities for targeted intervention. Journal of Clinical Investigation. https:\/\/doi.org\/10.1172\/JCI191943","journal-title":"Journal of Clinical Investigation"},{"key":"10326_CR63","doi-asserted-by":"publisher","unstructured":"Jimenez-Sanchez, A., Persad, S., Hayashi, A., Umeda, S., Sharma, R., Xie, Y., Mehta, A., Park, W., Masilionis, I., Chu, T. et al. (2025). Transcriptomic plasticity is a hallmark of metastatic pancreatic cancer.\u00a0Cancer Research.\u00a0https:\/\/doi.org\/10.1158\/0008-5472.CAN-25-1117","DOI":"10.1158\/0008-5472.CAN-25-1117"},{"issue":"12","key":"10326_CR64","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.neo.2021.11.007","volume":"23","author":"B Bozoky","year":"2021","unstructured":"Bozoky, B., Fernandez Moro, C., Strell, C., Geyer, N., Heuchel, R. L., Lohr, J. M., Ernberg, I., Szekely, L., Gerling, M., & Bozoky, B. (2021). Stabilization of the classical phenotype upon integration of pancreatic cancer cells into the duodenal epithelium. Neoplasia, 23(12), 1300\u20131306.","journal-title":"Neoplasia"},{"key":"10326_CR65","doi-asserted-by":"publisher","DOI":"10.1172\/JCI191945","author":"V Pantazopoulou","year":"2025","unstructured":"Pantazopoulou, V., Kubota, C. S., Ogawa, S., Gulay, K. C. M., Lin, X., Song, H., Weitz, J. R., Tiriac, H., Lowy, A. M., & Engle, D. D. (2025). Experimental models of pancreas cancer: What has been the impact for precision medicine? Journal of Clinical Investigation. https:\/\/doi.org\/10.1172\/JCI191945","journal-title":"Journal of Clinical Investigation"},{"issue":"1","key":"10326_CR66","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s12276-024-01378-w","volume":"57","author":"J Xu","year":"2025","unstructured":"Xu, J., Pham, M. D., Corbo, V., Ponz-Sarvise, M., Oni, T., Ohlund, D., & Hwang, C. I. (2025). Advancing pancreatic cancer research and therapeutics: The transformative role of organoid technology. Experimental & Molecular Medicine, 57(1), 50\u201358.","journal-title":"Experimental & Molecular Medicine"},{"issue":"19","key":"10326_CR67","doi-asserted-by":"publisher","first-page":"3549","DOI":"10.1158\/0008-5472.CAN-22-1742","volume":"82","author":"KL Pitter","year":"2022","unstructured":"Pitter, K. L., Grbovic-Huezo, O., Joost, S., Singhal, A., Blum, M., Wu, K., Holm, M., Ferrena, A., Bhutkar, A., Hudson, A., et al. (2022). Systematic comparison of pancreatic ductal adenocarcinoma models identifies a conserved highly plastic basal cell state. Cancer Research, 82(19), 3549\u20133560.","journal-title":"Cancer Research"},{"key":"10326_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-024-01498-5","author":"H Tamagawa","year":"2024","unstructured":"Tamagawa, H., Fujii, M., Togasaki, K., Seino, T., Kawasaki, S., Takano, A., Toshimitsu, K., Takahashi, S., Ohta, Y., Matano, M., et al. (2024). Wnt-deficient and hypoxic environment orchestrates squamous reprogramming of human pancreatic ductal adenocarcinoma. Nature Cell Biology. https:\/\/doi.org\/10.1038\/s41556-024-01498-5","journal-title":"Nature Cell Biology"},{"issue":"7","key":"10326_CR69","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s00535-024-02103-0","volume":"59","author":"K Matsumoto","year":"2024","unstructured":"Matsumoto, K., Fujimori, N., Ichihara, K., Takeno, A., Murakami, M., Ohno, A., Kakehashi, S., Teramatsu, K., Ueda, K., Nakata, K., et al. (2024). Patient-derived organoids of pancreatic ductal adenocarcinoma for subtype determination and clinical outcome prediction. Journal of Gastroenterology, 59(7), 629\u2013640.","journal-title":"Journal of Gastroenterology"},{"key":"10326_CR70","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1327772","volume":"12","author":"K Kumano","year":"2024","unstructured":"Kumano, K., Nakahashi, H., Louphrasitthiphol, P., Kuroda, Y., Miyazaki, Y., Shimomura, O., Hashimoto, S., Akashi, Y., Mathis, B. J., Kim, J., et al. (2024). Hypoxia at 3D organoid establishment selects essential subclones within heterogenous pancreatic cancer. Frontiers in Cell and Developmental Biology, 12, Article 1327772.","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"1","key":"10326_CR71","doi-asserted-by":"publisher","first-page":"23610","DOI":"10.1038\/s41598-025-98344-x","volume":"15","author":"N Landon-Brace","year":"2025","unstructured":"Landon-Brace, N., Latour, S., Innes, B. T., Nurse, M., Cadavid, J. L., Co, I. L., Tan, C. M., Nowlan, F., Drissler, S., Notta, F., et al. (2025). Analysis of an engineered organoid model of pancreatic cancer identifies hypoxia as a contributing factor in determining transcriptional subtypes. Science and Reports, 15(1), 23610.","journal-title":"Science and Reports"},{"key":"10326_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2025.115642","volume":"224","author":"J Gout","year":"2025","unstructured":"Gout, J., Ekizce, M., Roger, E., & Kleger, A. (2025). Pancreatic organoids as cancer avatars for true personalized medicine. Advanced Drug Delivery Reviews, 224, Article 115642.","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"7742","key":"10326_CR73","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41586-019-0891-2","volume":"566","author":"HA Messal","year":"2019","unstructured":"Messal, H. A., Alt, S., Ferreira, R. M. M., Gribben, C., Wang, V. M., Cotoi, C. G., Salbreux, G., & Behrens, A. (2019). Tissue curvature and apicobasal mechanical tension imbalance instruct cancer morphogenesis. Nature, 566(7742), 126\u2013130.","journal-title":"Nature"},{"issue":"1","key":"10326_CR74","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s43018-019-0010-1","volume":"1","author":"A Hayashi","year":"2020","unstructured":"Hayashi, A., Fan, J., Chen, R., Ho, Y. J., Makohon-Moore, A. P., Lecomte, N., Zhong, Y., Hong, J., Huang, J., Sakamoto, H., et al. (2020). A unifying paradigm for transcriptional heterogeneity and squamous features in pancreatic ductal adenocarcinoma. Nature Cancer, 1(1), 59\u201374.","journal-title":"Nature Cancer"},{"issue":"18","key":"10326_CR75","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.1158\/0008-5472.CAN-14-3363","volume":"75","author":"TT Dang","year":"2015","unstructured":"Dang, T. T., Esparza, M. A., Maine, E. A., Westcott, J. M., & Pearson, G. W. (2015). DeltaNp63alpha promotes breast cancer cell motility through the selective activation of components of the epithelial-to-mesenchymal transition program. Cancer Research, 75(18), 3925\u20133935.","journal-title":"Cancer Research"},{"issue":"8012","key":"10326_CR76","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/s41586-024-07302-6","volume":"629","author":"P Karras","year":"2024","unstructured":"Karras, P., Black, J. R. M., McGranahan, N., & Marine, J. C. (2024). Decoding the interplay between genetic and non-genetic drivers of metastasis. Nature, 629(8012), 543\u2013554.","journal-title":"Nature"},{"issue":"1","key":"10326_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-60808-z","volume":"16","author":"JJ Knox","year":"2025","unstructured":"Knox, J. J., Jang, G. H., Grant, R. C., Zhang, A., Ma, L., Elimova, E., Jang, R., Moore, M., Biagi, J., Tehfe, M., et al. (2025). Whole genome and transcriptome profiling in advanced pancreatic cancer patients on the COMPASS trial. Nature Communications, 16(1), Article 5919.","journal-title":"Nature Communications"},{"key":"10326_CR78","doi-asserted-by":"publisher","DOI":"10.1172\/JCI191939","author":"K Drizyte-Miller","year":"2025","unstructured":"Drizyte-Miller, K., Talabi, T., Somasundaram, A., Cox, A. D., & Der, C. J. (2025). KRAS: The Achilles\u2019 heel of pancreas cancer biology. Journal of Clinical Investigation. https:\/\/doi.org\/10.1172\/JCI191939","journal-title":"Journal of Clinical Investigation"},{"issue":"1","key":"10326_CR79","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-025-03569-x","volume":"16","author":"L Wang","year":"2025","unstructured":"Wang, L., Wei, D., Li, S., & Jiang, S. (2025). Advances in biomarkers of resistance to KRAS mutation-targeted inhibitors. Discovery Oncology, 16(1), Article 1834.","journal-title":"Discovery Oncology"},{"issue":"11","key":"10326_CR80","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1158\/2159-8290.CD-24-0177","volume":"14","author":"J Dilly","year":"2024","unstructured":"Dilly, J., Hoffman, M. T., Abbassi, L., Li, Z., Paradiso, F., Parent, B. D., Hennessey, C. J., Jordan, A. C., Morgado, M., Dasgupta, S., et al. (2024). Mechanisms of resistance to oncogenic KRAS inhibition in pancreatic cancer. Cancer Discovery, 14(11), 2135\u20132161.","journal-title":"Cancer Discovery"},{"issue":"11","key":"10326_CR81","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1158\/2159-8290.CD-24-0740","volume":"14","author":"A Singhal","year":"2024","unstructured":"Singhal, A., Styers, H. C., Rub, J., Li, Z., Torborg, S. R., Kim, J. Y., Grbovic-Huezo, O., Feng, H., Tarcan, Z. C., Sahin Ozkan, H., et al. (2024). A classical epithelial state drives acute resistance to KRAS inhibition in pancreatic cancer. Cancer Discovery, 14(11), 2122\u20132134.","journal-title":"Cancer Discovery"},{"issue":"1","key":"10326_CR82","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00659-4","volume":"6","author":"S Wang","year":"2021","unstructured":"Wang, S., Zheng, Y., Yang, F., Zhu, L., Zhu, X. Q., Wang, Z. F., Wu, X. L., Zhou, C. H., Yan, J. Y., Hu, B. Y., et al. (2021). The molecular biology of pancreatic adenocarcinoma: Translational challenges and clinical perspectives. Signal Transduction and Targeted Therapy, 6(1), Article 249.","journal-title":"Signal Transduction and Targeted Therapy"}],"container-title":["Cancer and Metastasis Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-026-10326-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10555-026-10326-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-026-10326-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:48:27Z","timestamp":1773290907000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10555-026-10326-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["10326"],"URL":"https:\/\/doi.org\/10.1007\/s10555-026-10326-1","relation":{},"ISSN":["1573-7233"],"issn-type":[{"value":"1573-7233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,12]]},"assertion":[{"value":"6 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"14"}}